Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling
{{output}}
Cost-effectiveness analyses often inform healthcare reimbursement decisions. The preferred measure of effectiveness is the quality adjusted life year (QALY) gained, where the quality of life adjustment is measured in terms of utility. Areas covered: We assesse... ...
